Skip to main content
Article thumbnail
Location of Repository

Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes

By Melissa W. Boulé, Courtney Broughton, Fabienne Mackay, Shizuo Akira, Ann Marshak-Rothstein and Ian R. Rifkin


Dendritic cell (DC) activation by nucleic acid–containing immunoglobulin (Ig)G complexes has been implicated in systemic lupus erythematosus (SLE) pathogenesis. However, the mechanisms responsible for activation and subsequent disease induction are not completely understood. Here we show that murine DCs are much more effectively activated by immune complexes that contain IgG bound to chromatin than by immune complexes that contain foreign protein. Activation by these chromatin immune complexes occurs by two distinct pathways. One pathway involves dual engagement of the Fc receptor FcγRIII and Toll-like receptor (TLR)9, whereas the other is TLR9 independent. Furthermore, there is a characteristic cytokine profile elicited by the chromatin immune complexes that distinguishes this response from that of conventional TLR ligands, notably the induction of BAFF and the lack of induction of interleukin 12. The data establish a critical role for self-antigen in DC activation and explain how the innate immune system might drive the adaptive immune response in SLE

Topics: Article
Publisher: The Rockefeller University Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2002). A blast from the past: clearance of apoptotic cells regulates immune responses.
  2. (2000). A Toll-like receptor recognizes bacterial DNA.
  3. (2003). Activation of autoreactive B cells by CpG dsDNA.
  4. (1999). Activation of targettissue immune-recognition molecules by double-stranded polynucleotides.
  5. (2002). Activation of the innate immunity in Drosophila by endogenous chromosomal DNA that escaped apoptotic degradation. Genes Dev.
  6. (1998). Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
  7. (1999). Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
  8. (2002). Antitumor monoclonal antibodies en-Dendritic Cell Activation by Chromatin–IgG Complexes 1640 hance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells.
  9. APRIL: a tutorial on B cell survival.
  10. (2002). Arthritis critically dependent on innate immune system players.
  11. (2000). Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins.
  12. (2002). Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.
  13. (1995). C1q-binding immunoglobulin G in MRL/l mice consists of immune complexes containing antibodies to DNA.
  14. (2002). Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
  15. (1991). Complement deficiency and disease.
  16. (1987). CpG islands as gene markers in the vertebrate nucleus. Trends Genet.
  17. (1998). CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species.
  18. (2002). CpG motifs in bacterial DNA and their immune effects.
  19. CpG motifs in bacterial DNA trigger direct B-cell activation.
  20. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
  21. (2001). Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.
  22. (2002). DCs induce CD40-independent immunoglobulin class switching through BLyS
  23. (2002). Delayed apoptotic cell clearance and lupuslike autoimmunity in mice lacking the c-mer membrane tyrosine kinase.
  24. (1998). Dendritic cells and the control of immunity.
  25. (2001). Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol.
  26. (2001). Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
  27. (2003). Effect of cytofectins on the immune response of murine macrophages to mammalian DNA.
  28. (1990). Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone.
  29. (2001). Evidence for an interferoninducible gene, Ifi202, in the susceptibility to systemic lupus.
  30. (1999). Fc receptor signaling and trafficking: a connection for antigen processing.
  31. (1999). Fc receptor–mediated induction of dendritic cell maturation and major histocompatibility complex class I–restricted antigen presentation after immune complex internalization.
  32. (2002). Fc receptors and cross-presentation in dendritic cells.
  33. (2000). Features of systemic lupus erythematosus in Dnase1-deficient mice.
  34. (2003). G-CSF–stimulated neutrophils are a prominent source of functional BLyS.
  35. (2001). Genomic DNA released by dying cells induces the maturation of APCs.
  36. (1998). Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
  37. (2001). IgG Fc receptors.
  38. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells.
  39. (1990). Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes.
  40. (2003). Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation.
  41. (2001). Importance of CpG dinucleotides in activation of natural IFN- -producing cells by a lupus-related oligodeoxynucleotide.
  42. (2002). Inducing tumor immunity through the selective engagement of activating Fc receptors on dendritic cells.
  43. (2001). Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.
  44. (2003). Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells. Antisense Nucleic Acid Drug Dev.
  45. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.
  46. (2003). Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
  47. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.
  48. (2002). Microbial recognition via Toll-like receptordependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering.
  49. (2004). mRNA is an endogenous ligand for Toll-like receptor 3.
  50. (2001). Mutation of DNASE1 in people with systemic lupus erythematosus.
  51. (2001). Phagocytosis and clearance of apoptotic cells is mediated by MER.
  52. (1995). Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.
  53. (2002). Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
  54. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
  55. (2004). Recognition of single-stranded RNA viruses by Toll-like receptor
  56. (2002). Roles of Fc receptors in autoimmunity.
  57. Selective suppression of interleukin-12 induction after macrophage receptor ligation.
  58. (1998). Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.
  59. (1999). Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity.
  60. (2002). Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.
  61. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.
  62. (1991). Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA.
  63. Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells.
  64. (2003). Subcellular localization of Toll-like receptor 3 in human dendritic cells.
  65. (1990). Subnucleosome structures as substrates in enzyme-linked immunosorbent assays.
  66. (2001). Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens.
  67. (2001). Synthesis and release of B-lymphocyte stimulator from myeloid cells.
  68. (1996). Systemic lupus erythematosus.
  69. (2000). TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
  70. (1998). Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function.
  71. (1997). The chromosomal distribution of CpG islands in the mouse: evidence for genome scrambling in the rodent lineage.
  72. (2000). The induction of tolerance by dendritic cells that have captured apoptotic cells.
  73. (2003). Tolerogenic dendritic cells.
  74. (2001). Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
  75. (2001). Toll-like receptors: critical proteins linking innate and acquired immunity.
  76. (2003). Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells.
  77. (2003). Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.